دورية أكاديمية

Transcription Factor-Targeted Therapies in Inflammatory Bowel Disease.

التفاصيل البيبلوغرافية
العنوان: Transcription Factor-Targeted Therapies in Inflammatory Bowel Disease.
المؤلفون: Mitsuyama, Keiichi, Suzuki, Asuka, Tomiyasu, Nobuo, Takaki, Kosuke, Toyonaga, Atsushi, Sata, Michio
المصدر: Digestion; 2001 Supplement 1, Vol. 63, p68-72, 5p, 2 Diagrams, 1 Chart
مصطلحات موضوعية: TRANSCRIPTION factors, CYTOKINES, INFLAMMATORY bowel diseases, ULCERATIVE colitis, CROHN'S disease
مستخلص: Although the causes of inflammatory bowel disease currently are not fully understood, increasing evidence implicates cytokines as key factors in the development of this disorder. The rationale for cytokine-targeted therapy for inflammatory bowel disease has been refined significantly, and clinical studies have been initiated. Recent investigations have focused on transcription factors that regulate production and activation of cytokines, including the nuclear factor-κB, the p38 mitogen-activated protein kinase, the peroxisome proliferator-activated receptor-γ, and the Janus kinases/signal transducers and activator of transcription pathways. Although their exact role in inflammatory bowel disease is still unknown, further studies may lead to identification of additional possible targets for therapeutic intervention that could improve management of the disease.Copyright © 2001 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
Copyright of Digestion is the property of Karger AG and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00122823
DOI:10.1159/000051914